STXBP1脑病:连接神经发育障碍与α-突触核蛋白病?
本文综述STXBP1(Munc18-1)致病变异导致的早发性神经认知疾病,最常见为早期婴儿癫痫性脑病4型(EIEE4),伴发育迟缓/智力障碍、自闭症谱系障碍和运动障碍。基础研究显示STXBP1敲除引起围产期神经退行性变,且STXBP1调控α-突触核蛋白的自复制聚集,提示EIEE的神经发育可能受共存的突触核蛋白病机制进一步影响。
要点
- STXBP1致病变异导致EIEE4,现有抗癫痫药物控制癫痫发作效果有限。
- STXBP1敲除或突触前胞吐机制蛋白缺失引起围产期广泛神经退行性变。
- STXBP1调控α-突触核蛋白自复制聚集,EIEE可能与突触核蛋白病机制共存。
核心结论
- STXBP1功能、EIEE与神经退行性突触核蛋白病之间存在引人注目的联系,EIEE的神经发育可能受共存的突触核蛋白病机制进一步影响。
研究设计与样本
- 本文为综述,未报告检索范围与样本量。
主要发现
- STXBP1致病变异导致早发性神经认知疾病,最常见为EIEE4,伴发育迟缓/智力障碍、自闭症谱系障碍和运动障碍。
- 部分年长受累个体出现锥体外系特征,类似早发性帕金森综合征。
- STXBP1或突触前胞吐机制其他蛋白的基因敲除导致围产期广泛神经退行性变。
- STXBP1调控α-突触核蛋白的自复制聚集,α-突触核蛋白参与包括帕金森病在内的突触核蛋白病。
关键数值与推荐
- 现有抗癫痫药物在EIEE4中控制癫痫发作效果有限,且无针对其他神经特征的精准药物方法。
临床怎么用
- 临床应关注STXBP1脑病患者除癫痫外的发育迟缓、自闭症谱系障碍及运动障碍等神经特征。
- 对年长STXBP1脑病患者需警惕锥体外系特征的出现。
局限性
- 本文为综述,未报告系统检索策略与纳入标准。
- STXBP1调控α-突触核蛋白聚集的证据主要来自基础研究,临床转化尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
De novo pathogenic variants in STXBP1 encoding syntaxin1-binding protein (STXBP1, also known as Munc18-1) lead to a range of early-onset neurocognitive conditions, most commonly early infantile epileptic encephalopathy type 4 (EIEE4, also called STXBP1 encephalopathy), a severe form of epilepsy associated with developmental delay/intellectual disability. Other neurologic features include autism spectrum disorder and movement disorders. The progression of neurologic symptoms has been reported in a few older affected individuals, with the appearance of extrapyramidal features, reminiscent of early onset parkinsonism. Understanding the pathologic process is critical to improving therapies, as currently available antiepileptic drugs have shown limited success in controlling seizures in EIEE4 and there is no precision medication approach for the other neurologic features of the disorder. Basic research shows that genetic knockout of STXBP1 or other presynaptic proteins of the exocytic machinery leads to widespread perinatal neurodegeneration. The mechanism that regulates this effect is under scrutiny but shares intriguing hallmarks with classical neurodegenerative diseases, albeit appearing early during brain development. Most critically, recent evidence has revealed that STXBP1 controls the self-replicating aggregation of α-synuclein, a presynaptic protein involved in various neurodegenerative diseases that are collectively known as synucleinopathies, including Parkinson disease. In this review, we examine the tantalizing link among STXBP1 function, EIEE, and the neurodegenerative synucleinopathies, and suggest that neural development in EIEE could be further affected by concurrent synucleinopathic mechanisms.
引用
- Lanoue V, Chai YJ, Brouillet JZ, et al. STXBP1 encephalopathy: Connecting neurodevelopmental disorders with α-synucleinopathies? Neurology. 2019. PMID: 31221716. doi:10.1212/WNL.0000000000007786
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。